Modulation of the Inflammatory Signature in an Experimental Autoimmune Encephalomyelitis Model through Treatment with Fasciola hepatica-Derived Recombinant Fatty Acid Binding Protein (rFh15)
The anti-inflammatory effects of rFh15 suggest that it could be further evaluated and applied in autoimmune disorders as a safe helminth therapy component.
Authors
- Mona Oraei
- Behrouz Robat-Jazi (ORCID: https://orcid.org/0000-0001-7366-0972)
- Mohammad Reza Bolouri
- Reza Falak (ORCID: https://orcid.org/0000-0002-1842-2952)
- Fereshteh Dalouchi
- Ali Akbar Saboor-Yaraghi (ORCID: https://orcid.org/0000-0001-8612-4773)
- Alireza Sadeghipour (ORCID: https://orcid.org/0000-0002-4590-1318)
- Maryam Hajizadeh (ORCID: https://orcid.org/0000-0003-1424-499X)
- Nesa Rashidi
- Leila Masoori (ORCID: https://orcid.org/0000-0002-8852-1075)
- Maryam Sahlolbei (ORCID: https://orcid.org/0000-0001-8575-1273)
- Nahid Jalallou (ORCID: https://orcid.org/0000-0003-2142-4526)
- Mohammad Hossein Kazemi (ORCID: https://orcid.org/0000-0002-2899-9755)
- Ahmad Reza Meamar (ORCID: https://orcid.org/0000-0002-8673-6603)
- Azam Samei
Institutions
- Iran University of Medical Sciences (IR)
- Kashan University of Medical Sciences (IR)
- Aja University of Medical Sciences (IR)
- Lorestan University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Endocrine Metabolic & Immune Disorders - Drug Targets
- Published
- 2025-04-22
- DOI
- https://doi.org/10.2174/0118715303336969250328052842
- Primary Topic
- Helminth infection and control
- Type
- article
- Field-Weighted Citation Impact
- 0.00